Physician profile
Smita Patel
NPI 1487665600
$30,328.76
in general payments reported to CMS, 2019-2025
8 companies · $20K in 2025
The $20K reported for 2025 was more than what 93% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2022: $53.19 · 2024: $9,924 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $5,600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400 · Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,600.00 |
| Travel and Lodging | $5,599.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
| Food and Beverage | $535.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18,799.22 | 2024-2025 | Kisunla |
| Eli Lilly and Company | $10,950.50 | 2025 | Kisunla |
| Janssen Scientific Affairs, LLC | $197.98 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2019 | |
| Pfizer INC. | $115.68 | 2025 | |
| Ucb, INC. | $72.50 | 2025 | Rystiggo |
| Genentech USA, INC. | $53.19 | 2022 | |
| Grifols USA, LLC | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smita Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.